Early postnatal dexamethasone treatment and increased incidence of cerebral palsy

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 83, Issue 3, 2000, Pages

  Shinwell, E S ^a   Dollberg, S ^j   Arbel, E ^k   Goldberg, M ^l   Gur, I ^m   Naor, N ⁿ   Sirota, L ⁿ   Mogilner, S ^a   Zaritsky, A ^o   Barak, M ^p   Gottfried, E ^q   Karplus, M ^b   Reich, D ^c   Weintraub, Z ^d   Blazer, S ^e   Bader, D ^f   Yurman, S ^g   Dolfin, T ^h   Kogan, A ⁱ  

^a KAPLAN MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HAEMEK MEDICAL CENTER   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

^e RAMBAM MEDICAL CENTER   (Israel)

^f BNAI ZION MEDICAL CENTER   (Israel)

^g HILLEL YAFFE MEDICAL CENTER   (Israel)

^h MEIR MEDICAL CENTER   (Israel)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^k WOLFSON MEDICAL CENTER   (Israel)

^l ASSAF HAROFEH MEDICAL CENTER   (Israel)

^m BIKUR CHOLIM HOSPITAL   (Israel)

ⁿ RABIN MEDICAL CENTER   (Israel)

^o BARZILAI MEDICAL CENTER   (Israel)

^p Nahariya Regional Medical Center   (Israel)

^q Rebecca Sieff Government Hospital   (Israel)

more..

Author keywords

Bronchopulmonary dysplasia; Cerebral palsy; Chronic lung disease; Dexamethasone; Steroids

Indexed keywords

DEXAMETHASONE; PLACEBO; SODIUM CHLORIDE; SURFACTANT TA;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; ENCEPHALOMALACIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NEWBORN MORTALITY; POSTNATAL CARE; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME; SPASTIC PARESIS;

EID: 0033769623     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.83.3.f177     Document Type: Article

References (27)

1. Clinical trials of postnatal corticosteroids: Inhaled and systemic
2. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
3. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome
4. A single dose of dexamethasone (Dex) given at delivery to infants < 28 weeks gestation results in improved lung function, early extubation, higher BP and less PDA
5. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in sufactant-treated infants
6. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome
7. Early intravenous dexamethasone (Dex) for the prevention of BPD in surfactant-treated babies with RDS
8. Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants
9. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome
10. Early postnatal dexamethasone therapy in premature infants with respiratory distress syndrome: A double-blind controlled study
11. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter, clinical trial
12. Early dexamethasone therapy in premature infants: A follow-up study
13. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age
14. Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure
15. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
16. Controlled trial of dexamethasoone in neonatal chronic lung disease: A 3-year follow-up
17. Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW < 1500 grams) who are ventilator dependent at 4 weeks of age
18. Dexamethasone in neonatal chronic lung disease: Pulmonary effects and intracranial complications
19. Dexamethasone changes brain monamine metabolism and aggravates ischemic neuronal damage in rats
20. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain
21. Perinatal glucocoticoids disrupt learning: A sexually dimorphic response
22. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants
23. Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats
24. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants
25. Toxic effects of sulfite in combination with peroxynitrite on neuronal cells
26. Evidence-based medicine
27. Follow-up for high risk neonates